Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director
CC transcript
Inv. presentation

MYRIAD GENETICS INC (MYGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 8-K Quarterly results
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "SEPARATION AND CONSULTING AGREEMENT AND RELEASE OF CLAIMS"
09/27/2023 4 Riggsbee Richard Bryan (CFO) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Paid exercise price by delivering 4,517 shares @ $15.99, valued at $72.2k
09/27/2023 4 Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Paid exercise price by delivering 3,523 shares @ $15.99, valued at $56.3k
09/27/2023 4 Lambert Nicole (COO) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Paid exercise price by delivering 4,402 shares @ $15.99, valued at $70.4k
09/27/2023 4 Haas Kevin Richard (Chief Technology Officer) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Paid exercise price by delivering 858 shares @ $15.99, valued at $13.7k
09/27/2023 4 Muzzey Dale (Chief Scientific Officer) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Paid exercise price by delivering 133 shares @ $15.99, valued at $2.1k
08/14/2023 4 DIAZ PAUL J (President and CEO) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Paid exercise price by delivering 22,943 shares @ $17.89, valued at $410.5k
Paid exercise price by delivering 51,292 shares @ $17.89, valued at $917.6k
08/04/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "Myriad Genetics Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Revenue and Adjusted EPS Guidance&#59; Generates the Fourth Consecutive Quarter of Double-Digit Year-Over-Year Testing Volume Growth"
07/06/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "ASSET BASED LENDING",
"PLEDGE AND SECURITY AGREEMENT",
"Million Asset-Based Credit Facility SALT LAKE CITY, July 6, 2023"
06/02/2023 4 BISARO PAUL (Director) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Granted 7,575 shares @ $0
06/02/2023 4 Kumar Rashmi (Director) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Granted 15,151 shares @ $0
06/02/2023 4 Skovronsky Daniel (Director) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Granted 15,151 shares @ $0
06/02/2023 4 SPIEGELMAN DANIEL K (Director) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Granted 15,151 shares @ $0
Sold 8,638 shares @ $23.01, valued at $198.8k
06/02/2023 4 Reitan Colleen F (Director) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Granted 15,151 shares @ $0
06/02/2023 4 Newcomer Lee Nisley (Director) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Granted 15,151 shares @ $0
06/02/2023 4 Dreismann Heinrich (Director) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Granted 15,151 shares @ $0
06/02/2023 4 Phanstiel S. Louise (Director) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Granted 15,151 shares @ $0
06/02/2023 8-K Appointed a new director
06/02/2023 144 Form 144 - Report of proposed sale of securities:
06/01/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 4 Munk Natalie (Chief Accounting Officer) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Paid exercise price by delivering 404 shares @ $23.72, valued at $9.6k
Paid exercise price by delivering 365 shares @ $23.72, valued at $8.7k
Paid exercise price by delivering 583 shares @ $23.72, valued at $13.8k
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy